Global Ranitidine (Zantac) Market Size, Share, Trends and Forecast 2022-2030

Description

Industry Insights
Due to the COVID-19 pandemic, the global Ranitidine (Zantac) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Ranitidine (Zantac) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Ranitidine (Zantac) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Ranitidine Capsule accounting for % of the Ranitidine (Zantac) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Ranitidine (Zantac) include Sanofi-Aventis, GlaxoSmithKline, Hi-Tech Pharmacal Co., Sun Pharma, Mylan Pharmaceuticals Inc. (and Mylan Laboratories), Dr. Reddy's Laboratories Inc., Sandoz Inc. (part of Novartis AG), Strides (and Strides Arcolab international) and Geri-Care Pharmaceuticals, etc. In terms of revenue, the global 3 largest players have a % market share of Ranitidine (Zantac) in 2021.

This report focuses on Ranitidine (Zantac) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Ranitidine (Zantac) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Ranitidine (Zantac) market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Ranitidine Capsule

Ranitidine Oral Tablet

Ranitidine Injectable Solution

Ranitidine Oral Syrup

Segment by Application

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sanofi-Aventis

GlaxoSmithKline

Hi-Tech Pharmacal Co.

Sun Pharma

Mylan Pharmaceuticals Inc. (and Mylan Laboratories)

Dr. Reddy's Laboratories Inc.

Sandoz Inc. (part of Novartis AG)

Strides (and Strides Arcolab international)

Geri-Care Pharmaceuticals

PAI Holdings, LLC

Teva Pharmaceuticals

Granules Pharmaceuticals Inc.

Glenmark Pharmaceuticals (and Glenmark Generics)

Apotex Inc. (and Apotex Corporation)

Hikma Pharmaceuticals (West-ward Pharmaceuticals)

TABLE OF CONTENT

1 Ranitidine (Zantac) Market Overview
1.1 Product Overview and Scope of Ranitidine (Zantac)

1.2 Ranitidine (Zantac) Segment by Type

1.2.1 Global Ranitidine (Zantac) Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Ranitidine Capsule

1.2.3 Ranitidine Oral Tablet

1.2.4 Ranitidine Injectable Solution

1.2.5 Ranitidine Oral Syrup

1.3 Ranitidine (Zantac) Segment by Application

1.3.1 Global Ranitidine (Zantac) Sales Comparison by Application: (2022-2028)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Global Ranitidine (Zantac) Market Size Estimates and Forecasts

1.4.1 Global Ranitidine (Zantac) Revenue 2017-2028

1.4.2 Global Ranitidine (Zantac) Sales 2017-2028

1.4.3 Ranitidine (Zantac) Market Size by Region: 2017 Versus 2021 Versus 2028

2 Ranitidine (Zantac) Market Competition by Manufacturers

2.1 Global Ranitidine (Zantac) Sales Market Share by Manufacturers (2017-2022)

2.2 Global Ranitidine (Zantac) Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Ranitidine (Zantac) Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Ranitidine (Zantac) Manufacturing Sites, Area Served, Product Type

2.5 Ranitidine (Zantac) Market Competitive Situation and Trends

2.5.1 Ranitidine (Zantac) Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Ranitidine (Zantac) Players Market Share by Revenue

2.5.3 Global Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ranitidine (Zantac) Retrospective Market Scenario by Region

3.1 Global Ranitidine (Zantac) Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Ranitidine (Zantac) Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Ranitidine (Zantac) Market Facts & Figures by Country

3.3.1 North America Ranitidine (Zantac) Sales by Country

3.3.2 North America Ranitidine (Zantac) Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Ranitidine (Zantac) Market Facts & Figures by Country

3.4.1 Europe Ranitidine (Zantac) Sales by Country

3.4.2 Europe Ranitidine (Zantac) Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Ranitidine (Zantac) Market Facts & Figures by Region

3.5.1 Asia Pacific Ranitidine (Zantac) Sales by Region

3.5.2 Asia Pacific Ranitidine (Zantac) Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Ranitidine (Zantac) Market Facts & Figures by Country

3.6.1 Latin America Ranitidine (Zantac) Sales by Country

3.6.2 Latin America Ranitidine (Zantac) Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Ranitidine (Zantac) Market Facts & Figures by Country

3.7.1 Middle East and Africa Ranitidine (Zantac) Sales by Country

3.7.2 Middle East and Africa Ranitidine (Zantac) Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Ranitidine (Zantac) Historic Market Analysis by Type

4.1 Global Ranitidine (Zantac) Sales Market Share by Type (2017-2022)

4.2 Global Ranitidine (Zantac) Revenue Market Share by Type (2017-2022)

4.3 Global Ranitidine (Zantac) Price by Type (2017-2022)

5 Global Ranitidine (Zantac) Historic Market Analysis by Application

5.1 Global Ranitidine (Zantac) Sales Market Share by Application (2017-2022)

5.2 Global Ranitidine (Zantac) Revenue Market Share by Application (2017-2022)

5.3 Global Ranitidine (Zantac) Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Sanofi-Aventis

6.1.1 Sanofi-Aventis Corporation Information

6.1.2 Sanofi-Aventis Description and Business Overview

6.1.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Sanofi-Aventis Ranitidine (Zantac) Product Portfolio

6.1.5 Sanofi-Aventis Recent Developments/Updates

6.2 GlaxoSmithKline

6.2.1 GlaxoSmithKline Corporation Information

6.2.2 GlaxoSmithKline Description and Business Overview

6.2.3 GlaxoSmithKline Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.2.4 GlaxoSmithKline Ranitidine (Zantac) Product Portfolio

6.2.5 GlaxoSmithKline Recent Developments/Updates

6.3 Hi-Tech Pharmacal Co.

6.3.1 Hi-Tech Pharmacal Co. Corporation Information

6.3.2 Hi-Tech Pharmacal Co. Description and Business Overview

6.3.3 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product Portfolio

6.3.5 Hi-Tech Pharmacal Co. Recent Developments/Updates

6.4 Sun Pharma

6.4.1 Sun Pharma Corporation Information

6.4.2 Sun Pharma Description and Business Overview

6.4.3 Sun Pharma Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Sun Pharma Ranitidine (Zantac) Product Portfolio

6.4.5 Sun Pharma Recent Developments/Updates

6.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories)

6.5.1 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Corporation Information

6.5.2 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Description and Business Overview

6.5.3 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product Portfolio

6.5.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Developments/Updates

6.6 Dr. Reddy's Laboratories Inc.

6.6.1 Dr. Reddy's Laboratories Inc. Corporation Information

6.6.2 Dr. Reddy's Laboratories Inc. Description and Business Overview

6.6.3 Dr. Reddy's Laboratories Inc. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Dr. Reddy's Laboratories Inc. Ranitidine (Zantac) Product Portfolio

6.6.5 Dr. Reddy's Laboratories Inc. Recent Developments/Updates

6.7 Sandoz Inc. (part of Novartis AG)

6.6.1 Sandoz Inc. (part of Novartis AG) Corporation Information

6.6.2 Sandoz Inc. (part of Novartis AG) Description and Business Overview

6.6.3 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product Portfolio

6.7.5 Sandoz Inc. (part of Novartis AG) Recent Developments/Updates

6.8 Strides (and Strides Arcolab international)

6.8.1 Strides (and Strides Arcolab international) Corporation Information

6.8.2 Strides (and Strides Arcolab international) Description and Business Overview

6.8.3 Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Strides (and Strides Arcolab international) Ranitidine (Zantac) Product Portfolio

6.8.5 Strides (and Strides Arcolab international) Recent Developments/Updates

6.9 Geri-Care Pharmaceuticals

6.9.1 Geri-Care Pharmaceuticals Corporation Information

6.9.2 Geri-Care Pharmaceuticals Description and Business Overview

6.9.3 Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Geri-Care Pharmaceuticals Ranitidine (Zantac) Product Portfolio

6.9.5 Geri-Care Pharmaceuticals Recent Developments/Updates

6.10 PAI Holdings, LLC

6.10.1 PAI Holdings, LLC Corporation Information

6.10.2 PAI Holdings, LLC Description and Business Overview

6.10.3 PAI Holdings, LLC Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.10.4 PAI Holdings, LLC Ranitidine (Zantac) Product Portfolio

6.10.5 PAI Holdings, LLC Recent Developments/Updates

6.11 Teva Pharmaceuticals

6.11.1 Teva Pharmaceuticals Corporation Information

6.11.2 Teva Pharmaceuticals Ranitidine (Zantac) Description and Business Overview

6.11.3 Teva Pharmaceuticals Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Teva Pharmaceuticals Ranitidine (Zantac) Product Portfolio

6.11.5 Teva Pharmaceuticals Recent Developments/Updates

6.12 Granules Pharmaceuticals Inc.

6.12.1 Granules Pharmaceuticals Inc. Corporation Information

6.12.2 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Description and Business Overview

6.12.3 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product Portfolio

6.12.5 Granules Pharmaceuticals Inc. Recent Developments/Updates

6.13 Glenmark Pharmaceuticals (and Glenmark Generics)

6.13.1 Glenmark Pharmaceuticals (and Glenmark Generics) Corporation Information

6.13.2 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Description and Business Overview

6.13.3 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product Portfolio

6.13.5 Glenmark Pharmaceuticals (and Glenmark Generics) Recent Developments/Updates

6.14 Apotex Inc. (and Apotex Corporation)

6.14.1 Apotex Inc. (and Apotex Corporation) Corporation Information

6.14.2 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Description and Business Overview

6.14.3 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product Portfolio

6.14.5 Apotex Inc. (and Apotex Corporation) Recent Developments/Updates

6.15 Hikma Pharmaceuticals (West-ward Pharmaceuticals)

6.15.1 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Corporation Information

6.15.2 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Description and Business Overview

6.15.3 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2017-2022)

6.15.4 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product Portfolio

6.15.5 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Developments/Updates

7 Ranitidine (Zantac) Manufacturing Cost Analysis

7.1 Ranitidine (Zantac) Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Ranitidine (Zantac)

7.4 Ranitidine (Zantac) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Ranitidine (Zantac) Distributors List

8.3 Ranitidine (Zantac) Customers

9 Ranitidine (Zantac) Market Dynamics

9.1 Ranitidine (Zantac) Industry Trends

9.2 Ranitidine (Zantac) Market Drivers

9.3 Ranitidine (Zantac) Market Challenges

9.4 Ranitidine (Zantac) Market Restraints

10 Global Market Forecast

10.1 Ranitidine (Zantac) Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Ranitidine (Zantac) by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Ranitidine (Zantac) by Type (2023-2028)

10.2 Ranitidine (Zantac) Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Ranitidine (Zantac) by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Ranitidine (Zantac) by Application (2023-2028)

10.3 Ranitidine (Zantac) Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Ranitidine (Zantac) by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Ranitidine (Zantac) by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample